Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI-Reference-Cited by-同舟云学术

Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI

Published:2021-11 Issue:21 Volume:78 Page:2060-2072
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Valgimigli Marco,Cao Davide,Angiolillo Dominick J.,Bangalore Sripal,Bhatt Deepak L.,Ge Junbo,Hermiller James,Makkar Raj R.,Neumann Franz-Josef,Saito Shigeru,Picon Hector,Toelg Ralph,Maksoud Aziz,Chehab Bassem M.,Choi James W.,Campo Gianluca,De la Torre Hernandez Jose M.,Kunadian Vijay,Sardella Gennaro,Thiele Holger,Varenne Olivier,Vranckx Pascal,Windecker Stephan,Zhou Yujie,Krucoff Mitchell W.,Ruster Karine,Zheng Yan,Mehran Roxana

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference36 articles.

1. Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey;Cao;Eur Heart J,2021

2. Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial;Mehran;Eur Heart J,2009

3. Trade-off of myocardial infarction vs bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial;Valgimigli;Eur Heart J,2017

4. Validation of the academic research consortium high bleeding risk definition in contemporary PCI patients;Cao;J Am Coll Cardiol,2020

5. Validation of high bleeding risk criteria and definition as proposed by the academic research consortium for high bleeding risk;Corpataux;Eur Heart J,2020

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Double Trouble: Dual Antiplatelet Therapy Duration Dilemma in Chronic Kidney Disease Patients With High Bleeding Risk;The American Journal of Cardiology;2024-09

2. 2024 ESC Guidelines for the management of chronic coronary syndromes;European Heart Journal;2024-08-30

3. One-Month Versus Three-Month Dual-Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney Disease;The American Journal of Cardiology;2024-08

4. Antiplatelet Therapy for Elderly Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention;Journal of Clinical Medicine;2024-07-19

5. One-month DAPT after biodegradable-polymer everolimus-eluting stent implantation in patients at high-bleeding risk: an individual patient data pooled analysis of the SENIOR and POEM trials;European Heart Journal Open;2024-07